Screening for Disorders of Lipid Metabolism and Familial Hyperlipidemia in Children and Adolescents With Increased Cardiovascular Risk Due to Chronic Diseases Such as Congenital Heart Disease, Chronic Inflammatory Bowel Disease, Celiac Disease and Rheumatic Disorders
Not applicable · Testing blood test, questionaire · 1 site · Alexandra Miriam Kiess
Official record & contacts on ClinicalTrials.gov ↗
In plain English
What this trial is testing
This study is testing blood test, questionaire as a screening approach. Condition(s) listed: Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors and Congenital Heart Disease.
It is open-label: participants know what they are receiving.
This study does not use drug-development phases (it may test a device, diet, procedure, app, or care approach).
Who can join
- Ages 6 to 18
- Any sex
Some of the main requirements, copied from the record:
- See the official record.
Only the trial team can confirm whether you qualify.
What's involved
- About 600 participants are expected to take part.
- Start date: 2026-08-01 (planned).
- Main results expected around 2027-01-31 (estimate from the record).
- 1 study site listed (1 marked recruiting) in Germany.
Main thing being measured
- Prevalence of elevated lipid levels and familial hyperlipidemias in our sample of chronically ill children and adolescents (6-12 months)
In the researchers’ words
Preventive measures are increasingly coming to the forefront of medicine. Many of these measures can be implemented as early as childhood and adolescence.
This is a short automatic summary built from the official record. A fuller plain-English card is coming; until then, please read the official record.
Questions to ask your doctor and the trial team
- Am I likely to qualify, given my health history?
- What would I have to do, and how often would I need to visit?
- Could I get a placebo? What happens to my current treatment?
- What are the possible risks and benefits?
- Are travel or other costs covered?
- What happens after the trial ends?
Official details
| Status | Recruiting |
|---|---|
| Phase | Not applicable |
| Study type | Interventional |
| Conditions | Lipid Metabolism Disorders; Lipid Metabolism, Inborn Errors; Congenital Heart Disease; Inflammatory Bowel Disease (IBD); Rheumatic Diseases; Celiac Disease in Children; Celiac Disease in Adolescents |
| Lead sponsor | Alexandra Miriam Kiess |
| Enrollment | 600 (estimated) |
| Start date | 2026-08-01 |
| Primary completion (est.) | 2027-01-31 |
| First posted | 2026-07-21 |
| Last updated | 2026-07-21 |
| Official title | Screening Auf Lipidstoffwechselstörungen Und familiäre Hyperlipidämien Bei Kindern Und Jugendlichen Mit erhöhtem kardiovaskulären Risiko Durch Chronische Erkrankungen Wie Angeborene Herzfehler, Chronisch entzündliche Darmerkrankungen, Zöliakie Sowie Rheumatische Erkrankungen |
| ClinicalTrials.gov ID | NCT07716488 |
Interventions
- blood test, questionaire (Other)
blood test + questionaire
Full eligibility criteria (from the record)
Inclusion Criteria: Patients aged 5 to 18 years who are being treated at the UKJ in one of our specialized pediatric clinics for a chronic condition-such as a congenital heart defect, chronic inflammatory bowel disease, celiac disease, or a rheumatic disease. Exclusion Criteria: Lack of consent from the patient or legal guardian(s)
Locations (1)
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Jena | Jena | Germany | Recruiting |
For contacts at each site, use the official record.
Information only, not medical advice. Talk to your doctor and the trial team before making any decision about a clinical trial.